EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 30 / No 12 (Décembre 2014) Med Sci (Paris), 30 12 (2014) 1136-1143 References
Free Access
Issue
Med Sci (Paris)
Volume 30, Number 12, Décembre 2014
Page(s) 1136 - 1143
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20143012017
Published online 24 December 2014
  1. Schenck CH, Bassetti CL, Arnulf I, Mignot E. English translations of the first clinical reports on narcolepsy and cataplexy by Westphal and Gélineau in the late 19th century, with commentary. J Clin Sleep Med 2007 ; 3 : 301–1. [PubMed] [Google Scholar]
  2. Gélineau JB. De la narcolepsie. Gazette des Hôpitaux Civils et Militaires 1880 ; 53 : 626–8 et 1881; 54 : 635-7. [Google Scholar]
  3. Billiard M. Narcolepsy. Clinical features and aetiology. Ann Clin Res 1985 ; 17 : 220–6. [PubMed] [Google Scholar]
  4. Parkes JD, Fenton G, Struthers G, et al. Record C: narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. QJM 1974 ; 43 : 525–36. [Google Scholar]
  5. Murray TJ, Foley A. Narcolepsy. Can Med Assoc J 1974 ; 110 : 63–6. [PubMed] [Google Scholar]
  6. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007 ; 369 : 499–511. [CrossRef] [PubMed] [Google Scholar]
  7. Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep 2002 ; 25 : 27–35. [PubMed] [Google Scholar]
  8. International Classification of Sleep Disorders, third edition (ICSD-3). American Academy of Sleep Medicine, 2014. http://www.aasmnet.org [Google Scholar]
  9. DSM-5 Development. In : DSM-5. The future of psychiatric diagnosis. American Psychiatric Association, 2013. [Google Scholar]
  10. Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013 ; 23 : 767–73. [CrossRef] [PubMed] [Google Scholar]
  11. Honda Y.. Census of narcolepsy, cataplexy, sleep life among teenagers in Fujisawa city. Sleep Res 1979 ; 8 : 191. [Google Scholar]
  12. Tashiro T, Kanbayashi T, Hishikawa Y.. An epidemiological study on prevalence of narcolepsy in Japanese. Sleep Res 1992 ; 1 (suppl) : 228. [Google Scholar]
  13. Lavie P, Peled R. Narcolepsy is a rare disease in Israel. Sleep 1987 ; 10 : 608–9. [PubMed] [Google Scholar]
  14. Wise MS. Childhood narcolepsy. Neurology 1998 ; 50 : S37–42. [CrossRef] [PubMed] [Google Scholar]
  15. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998 ; 50 : S16–22. [CrossRef] [PubMed] [Google Scholar]
  16. Overeem S, Black JL, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med Rev 2008 ; 12 : 95–107. [CrossRef] [PubMed] [Google Scholar]
  17. Pizza F, Franceschini C, Peltola H, et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain J Neurol 2013 ; 136 : 3787–95. [CrossRef] [Google Scholar]
  18. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999 ; 98 : 365–76. [CrossRef] [PubMed] [Google Scholar]
  19. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999 ; 98 : 437–51. [CrossRef] [PubMed] [Google Scholar]
  20. Tsujino N, Sakurai T. Orexin/hypocretin: A neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009 ; 61 : 162–76. [CrossRef] [PubMed] [Google Scholar]
  21. Nishino S, Takeshi S (eds). The orexin/hypocretin system, Physiology and pathophysiology, Humana press, 2005 : 416 p. [Google Scholar]
  22. Heier MS, Jansson TS, Gautvik KM. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy. J Clin Sleep Med 2011 , 7 : 653–8. [PubMed] [Google Scholar]
  23. Andlauer O, Moore H, Hong SC, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 2012 ; 35 : 1247–55. [PubMed] [Google Scholar]
  24. Mignot E, Hayduk R, Black J, et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997 ; 20 : 1012–20. [PubMed] [Google Scholar]
  25. Tafti M, Hor H, Dauvilliers Y, et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014 ; 37 : 19–25. [PubMed] [Google Scholar]
  26. Honda Y, Juji T (eds). HLA in narcolepsy, Springer, 1988 : 210 p. [Google Scholar]
  27. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 1984 ; 24 : 316–9. [CrossRef] [PubMed] [Google Scholar]
  28. Hallmayer J. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009 ; 41 : 708–11. [CrossRef] [PubMed] [Google Scholar]
  29. Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 2013 ; 9 : e1003270. [CrossRef] [PubMed] [Google Scholar]
  30. Han F, Faraco J, Dong XS, et al. Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet 2013 ; 9 : e1003880. [CrossRef] [PubMed] [Google Scholar]
  31. Winkelmann J, Lin L, Schormair B, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 2012 ; 21 : 2205–10. [CrossRef] [PubMed] [Google Scholar]
  32. Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china. Ann Neurol 2011 ; 70 : 410–7. [CrossRef] [PubMed] [Google Scholar]
  33. Han F, Lin L, Li J, et al. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 2013 ; 73 : 560. [Google Scholar]
  34. Vincent A. Encephalitis lethargica: part of a spectrum of post-streptococcal autoimmune diseases? Brain J Neurol 2004 ; 127 : 2–3. [CrossRef] [Google Scholar]
  35. Lehmann HC, Hartung HP, Kieseier BC, Hughes RAC. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis 2010 ; 10 : 643–51. [CrossRef] [PubMed] [Google Scholar]
  36. Dauvilliers Y, Arnulf I, Lecendreux M, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain J Neurol 2013 ; 136 : 2486–96. [CrossRef] [PubMed] [Google Scholar]
  37. Han F, Lin L, Li J, et al. Presentations of primary hypersomnia in Chinese children. Sleep 2011 ; 34 : 627–32. [PubMed] [Google Scholar]
  38. Aran A, Lin L, Nevsimalova S, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009 ; 32 : 979–83. [PubMed] [Google Scholar]
  39. Wijnans L, Lecomte C, de Vries C, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013 ; 31 : 1246–54. [CrossRef] [PubMed] [Google Scholar]
  40. Partinen M, Kornum BR, Plazzi G, et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014 ; 13 : 600–13. [CrossRef] [PubMed] [Google Scholar]
  41. Ahmed SS, Schur PH, Macdonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 2014 ; 50C : 1–11. [CrossRef] [PubMed] [Google Scholar]
  42. Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PloS One 2012 ; 7 : e33536. [Google Scholar]
  43. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012 ; 7 : e33723. [CrossRef] [PubMed] [Google Scholar]
  44. O’Flanagan D, Barret AS, Foley M, et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland, April 2009-December 2010. Euro Surveill 2014 ; 19 : 15–25. [PubMed] [Google Scholar]
  45. Dauvilliers Y, Montplaisir J, Cochen V, et al. Post-H1N1 narcolepsy-cataplexy. Sleep 2010 ; 33 : 1428–30. [PubMed] [Google Scholar]
  46. Winstone AM, Stellitano L, Verity C, et al. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014 ; doi : 10.1111/dmcn.12522 [Google Scholar]
  47. Mendes MFSG, de Campos Valladares Neto D, de Azevedo RA, Caramelli P. Narcolepsy after A/H1N1 vaccination. Clinics 2012 ; 67 : 77–8. [CrossRef] [Google Scholar]
  48. Montplaisir J, Petit D, Quinn MJ, et al. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PloS One 2014 ; 9 : e108489. [CrossRef] [PubMed] [Google Scholar]
  49. Duffy J, Weintraub E, Vellozzi C, DeStefano F. on behalf of the vaccine safety datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 2014 ; doi : 10.1212/WNL.0000000000000987 [Google Scholar]
  50. Nicolson C, Harvey R, Johnson R, et al. An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. Vaccine 2012 ; 30 : 745–51. [CrossRef] [PubMed] [Google Scholar]
  51. Robertson JS, Nicolson C, Harvey R, et al. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 2011 ; 29 : 1836–43. [CrossRef] [PubMed] [Google Scholar]
  52. Leroux-Roels I, Roman F, Forgus S, et al. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Vaccine 2010 ; 28 : 849–57. [CrossRef] [PubMed] [Google Scholar]
  53. Kornum BR, Kawashima M, Faraco J, et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011 ; 43 : 66–71. [CrossRef] [PubMed] [Google Scholar]
  54. Bergman P, Adori C, Vas S, et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci USA 2014 ; 111 : E3735–44. [CrossRef] [Google Scholar]
  55. Dauvilliers Y, Jaussent I, Lecendreux M, et al. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study. Brain Behav Immun 2014 ; 37 : 260–6. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.